Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InMode Ltd. stock logo
INMD
InMode
$17.37
+1.3%
$20.68
$16.96
$48.25
$1.44B2.161.59 million shs923,523 shs
LivaNova PLC stock logo
LIVN
LivaNova
$55.02
+1.9%
$53.77
$42.75
$59.86
$2.97B0.89609,997 shs643,372 shs
Natus Medical Incorporated stock logo
NTUS
Natus Medical
$32.96
$32.96
$20.90
$33.93
$1.14B0.22325,002 shs1,514 shs
ViewRay, Inc. stock logo
VRAY
ViewRay
$0.34
$0.02
$4.96
$4.59M0.817.51 million shs108.50 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InMode Ltd. stock logo
INMD
InMode
+1.34%-1.42%-15.06%-23.55%-53.96%
LivaNova PLC stock logo
LIVN
LivaNova
+1.87%+3.46%-1.71%+12.42%+12.82%
Natus Medical Incorporated stock logo
NTUS
Natus Medical
0.00%0.00%0.00%0.00%0.00%
ViewRay, Inc. stock logo
VRAY
ViewRay
0.00%0.00%0.00%0.00%-97.93%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
InMode Ltd. stock logo
INMD
InMode
3.246 of 5 stars
3.23.00.00.02.61.72.5
LivaNova PLC stock logo
LIVN
LivaNova
1.4126 of 5 stars
2.23.00.00.01.21.71.9
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/AN/AN/AN/AN/AN/AN/AN/A
ViewRay, Inc. stock logo
VRAY
ViewRay
1.5904 of 5 stars
3.00.00.04.40.01.70.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
InMode Ltd. stock logo
INMD
InMode
2.33
Hold$32.8088.83% Upside
LivaNova PLC stock logo
LIVN
LivaNova
2.40
Hold$64.4017.05% Upside
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/AN/AN/AN/A
ViewRay, Inc. stock logo
VRAY
ViewRay
2.00
Hold$1.33∞ Upside

Current Analyst Ratings

Latest LIVN, INMD, NTUS, and VRAY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/12/2024
InMode Ltd. stock logo
INMD
InMode
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$34.00 ➝ $33.00
4/9/2024
InMode Ltd. stock logo
INMD
InMode
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
3/27/2024
LivaNova PLC stock logo
LIVN
LivaNova
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$75.00
3/20/2024
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$72.00
2/26/2024
LivaNova PLC stock logo
LIVN
LivaNova
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$57.00 ➝ $61.00
2/22/2024
LivaNova PLC stock logo
LIVN
LivaNova
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$56.00 ➝ $62.00
2/21/2024
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$62.00 ➝ $72.00
2/20/2024
LivaNova PLC stock logo
LIVN
LivaNova
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$60.00 ➝ $70.00
2/15/2024
InMode Ltd. stock logo
INMD
InMode
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$32.00 ➝ $34.00
2/14/2024
InMode Ltd. stock logo
INMD
InMode
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$24.00 ➝ $26.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
InMode Ltd. stock logo
INMD
InMode
$492.05M2.96$2.21 per share7.87$6.68 per share2.60
LivaNova PLC stock logo
LIVN
LivaNova
$1.15B2.57$4.52 per share12.16$23.72 per share2.32
Natus Medical Incorporated stock logo
NTUS
Natus Medical
$473.44M2.41$2.02 per share16.34$12.44 per share2.65
ViewRay, Inc. stock logo
VRAY
ViewRay
$105.86M0.00N/AN/A$0.45 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
InMode Ltd. stock logo
INMD
InMode
$197.92M$2.307.557.90N/A40.22%29.80%27.02%5/2/2024 (Confirmed)
LivaNova PLC stock logo
LIVN
LivaNova
$17.55M$0.32171.9416.42N/A1.53%12.23%6.47%5/1/2024 (Confirmed)
Natus Medical Incorporated stock logo
NTUS
Natus Medical
$13.18M$0.3789.0820.99N/A2.65%10.15%7.65%N/A
ViewRay, Inc. stock logo
VRAY
ViewRay
-$107.33M-$0.60N/AN/AN/A-104.30%-120.48%-42.39%N/A

Latest LIVN, INMD, NTUS, and VRAY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
InMode Ltd. stock logo
INMD
InMode
$0.40N/A-$0.40N/AN/AN/A  
5/1/2024N/A
LivaNova PLC stock logo
LIVN
LivaNova
$0.47N/A-$0.47N/AN/AN/A  
2/21/202412/31/2023
LivaNova PLC stock logo
LIVN
LivaNova
$0.77$0.87+$0.10$1.44$287.65 million$310.10 million    
2/13/202412/31/2023
InMode Ltd. stock logo
INMD
InMode
$0.66$0.71+$0.05$0.64$124.77 million$126.80 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/AN/AN/AN/AN/A
ViewRay, Inc. stock logo
VRAY
ViewRay
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
InMode Ltd. stock logo
INMD
InMode
N/A
12.51
11.87
LivaNova PLC stock logo
LIVN
LivaNova
0.44
2.95
2.51
Natus Medical Incorporated stock logo
NTUS
Natus Medical
N/A
2.54
1.90
ViewRay, Inc. stock logo
VRAY
ViewRay
N/A
1.16
0.91

Ownership

Institutional Ownership

CompanyInstitutional Ownership
InMode Ltd. stock logo
INMD
InMode
68.04%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Natus Medical Incorporated stock logo
NTUS
Natus Medical
92.35%
ViewRay, Inc. stock logo
VRAY
ViewRay
92.97%

Insider Ownership

CompanyInsider Ownership
InMode Ltd. stock logo
INMD
InMode
6.92%
LivaNova PLC stock logo
LIVN
LivaNova
0.19%
Natus Medical Incorporated stock logo
NTUS
Natus Medical
1.20%
ViewRay, Inc. stock logo
VRAY
ViewRay
2.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
InMode Ltd. stock logo
INMD
InMode
58183.98 million78.17 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
2,90053.96 million53.85 millionOptionable
Natus Medical Incorporated stock logo
NTUS
Natus Medical
1,40034.58 million34.17 millionOptionable
ViewRay, Inc. stock logo
VRAY
ViewRay
295183.40 million178.82 millionOptionable

LIVN, NTUS, INMD, and VRAY Headlines

SourceHeadline
The best 4K Blu-ray players for 2024The best 4K Blu-ray players for 2024
digitaltrends.com - March 24 at 6:22 PM
VRAY Jan 2025 2.000 callVRAY Jan 2025 2.000 call
finance.yahoo.com - March 16 at 9:28 AM
VRAY Jan 2025 0.500 putVRAY Jan 2025 0.500 put
finance.yahoo.com - March 16 at 9:28 AM
VRAY Jan 2025 0.500 callVRAY Jan 2025 0.500 call
finance.yahoo.com - March 16 at 12:50 AM
VRAY Jan 2025 3.000 putVRAY Jan 2025 3.000 put
finance.yahoo.com - March 16 at 12:50 AM
Creating the Scene with V-Ray for 3ds MaxCreating the Scene with V-Ray for 3ds Max
archdaily.com - March 2 at 1:34 PM
How to Supercharge Your SketchUp Renders With V-Ray Lights and MaterialsHow to Supercharge Your SketchUp Renders With V-Ray Lights and Materials
archdaily.com - February 26 at 6:18 PM
ViewRay Inc VRAYQViewRay Inc VRAYQ
morningstar.com - November 4 at 7:06 AM
NUBURU Appoints Brian Knaley as new CEONUBURU Appoints Brian Knaley as new CEO
benzinga.com - November 1 at 5:27 PM
Open Letter to ViewRay Customers, Service, Software Engineers and Suppliers-Lets Preserve ViewRay TechnologyOpen Letter to ViewRay Customers, Service, Software Engineers and Suppliers-Let's Preserve ViewRay Technology
tmcnet.com - October 19 at 8:02 AM
Letter to ViewRay Lenders/Investment Bankers and Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global CompaniesLetter to ViewRay Lenders/Investment Bankers and Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies
benzinga.com - October 17 at 1:37 PM
ViewRay Inc (6L9.BE)ViewRay Inc (6L9.BE)
ca.finance.yahoo.com - August 20 at 6:13 PM
B. Riley Securities downgrades ViewRay Inc. (VRAY) rating to a NeutralB. Riley Securities downgrades ViewRay Inc. (VRAY) rating to a Neutral
knoxdaily.com - July 24 at 3:24 PM
ViewRay stock to be delisted from Nasdaq and moved to OTC ExchangeViewRay stock to be delisted from Nasdaq and moved to OTC Exchange
seekingalpha.com - July 21 at 6:20 PM
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC MarketsViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets
finance.yahoo.com - July 21 at 6:20 PM
Keeping an Eye on ViewRay Inc. (VRAY) After Insider Trading ActivityKeeping an Eye on ViewRay Inc. (VRAY) After Insider Trading Activity
knoxdaily.com - July 19 at 1:18 PM
Why ViewRay Stock Hit A New 52-Week Low TodayWhy ViewRay Stock Hit A New 52-Week Low Today
benzinga.com - July 18 at 8:33 PM
ViewRay, Inc.: ViewRay Files Voluntary Chapter 11 PetitionsViewRay, Inc.: ViewRay Files Voluntary Chapter 11 Petitions
finanznachrichten.de - July 18 at 10:32 AM
Why ViewRay (VRAY) Stock Hit A New 52-Week Low TodayWhy ViewRay (VRAY) Stock Hit A New 52-Week Low Today
msn.com - July 17 at 1:15 PM
Why Is ViewRay (VRAY) Stock Down 69% Today?Why Is ViewRay (VRAY) Stock Down 69% Today?
investorplace.com - July 17 at 12:04 PM
ViewRay® Files Voluntary Chapter 11 PetitionsViewRay® Files Voluntary Chapter 11 Petitions
finance.yahoo.com - July 17 at 8:15 AM
ViewRay Inc. (VRAY) may enjoy gains as insiders got busy in the recent daysViewRay Inc. (VRAY) may enjoy gains as insiders got busy in the recent days
knoxdaily.com - July 12 at 5:59 PM
ViewRay: Near-Term Bankruptcy Filing Might Be In The Cards - SellViewRay: Near-Term Bankruptcy Filing Might Be In The Cards - Sell
msn.com - July 7 at 9:16 AM
Analyzing ViewRay Inc. (VRAY) After Recent Trading ActivityAnalyzing ViewRay Inc. (VRAY) After Recent Trading Activity
knoxdaily.com - July 5 at 8:52 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

InMode logo

InMode

NASDAQ:INMD
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
LivaNova logo

LivaNova

NASDAQ:LIVN
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Natus Medical logo

Natus Medical

NASDAQ:NTUS
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.
ViewRay logo

ViewRay

NASDAQ:VRAY
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado.